Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cancer
    • CT lung cancer...

    CT lung cancer screening beneficial for female never-smokers, finds study

    Written by Medha Baranwal Baranwal Published On 2019-12-23T19:20:41+05:30  |  Updated On 23 Dec 2019 7:20 PM IST
    CT lung cancer screening beneficial for female never-smokers, finds study

    China: A recent study published in the journal Cancer Epidemiology, Biomarkers & Prevention throws light on whether CT lung cancer screening is beneficial for female never-smokers. Currently, the procedure is earmarked for smokers and former smokers.


    The study is important as 25% of lung cancer cases occur in people who never smoked and the proportion is considerably larger for Asian women -- about 60 to 80% of females lung cancer patients in Asia are never-smokers.


    Recently, various studies have shown that integrating risk-prediction models into CT lung screening eligibility criteria could help boost the efficiency of screening and prevent more cancer deaths than relying on the U.S. Preventive Services Task Force (USPSTF) guidelines.


    Chao A. Hsiung, Institute of Population Health Sciences, National Health Research Institutes, and colleagues formed an age-matched case-control study using data on NSFs in the Taiwan Genetic Epidemiology Study of Lung Adenocarcinoma and the Taiwan Biobank. The case-control study consisted of 1748 lung cancer patients and 6535 controls.


    Read Also: CT lung cancer screening useful and cost effective even in elderly, finds study

    They developed the Taiwanese NSF Lung Cancer Risk Models using genetic information and simplified questionnaire (TNSF-SQ) using an estimated age-specific lung cancer six-year incidence rate among Taiwanese NSFs. Performance evaluation was based on the newer independent datasets: Taiwan Lung Cancer Pharmacogenomics Study (LCPG) and Taiwan Biobank data after August 2016 (TWB2). The model considered various factors to determine risk, including a family history of lung cancer, history of the chronic obstructive pulmonary disorder, education level, and genetic information (i.e., the presence of 11 single nucleotide polymorphisms), among others.


    They applied their risk model to the data of 8,283 female never-smokers between the ages of 55 and 70, drawn from the Genetic Epidemiology Study of Lung Adenocarcinoma in Taiwan and the Taiwan Biobank before 2016.


    Key findings of the study include:




    • The AUC based on the NSFs aged 55-70 in LCPG and TWB2 was 0.714.

    • For women in TWB2 aged 55-70, 3.94% had a risk higher than 0.0151.

    • For women in LCPG aged 55-74, 27.03% had a risk higher than 0.0151.


    Read Also: MR spectroscopy aided test may replace CT in diagnosis of early Lung Cancer

    The risk-prediction model demonstrated good discriminative power overall and demonstrated the potential to identify female Asian never-smokers for CT lung screening, the researchers noted.


    "Our study may be useful for policymakers in screening program design. ... It might also be useful for [female never-smokers] or their doctors to get some idea about their risks for lung cancer and decide if they might benefit from CT lung cancer screening," they wrote.


    TNSF-SQ seems potentially useful in selecting Asian NSFs (never-smoking females) for LDCT (low-dose computed tomography) screening, they concluded.


    The study, "Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model," is published in the journal Cancer Epidemiology, Biomarkers & Prevention.


    DOI: 10.1158/1055-9965.EPI-19-1221

    Cancer Epidemiology Biomarkers & PreventionChao A. HsiungCT lung cancer screeningLung Cancernever-smokers
    Source : With inputs from Cancer Epidemiology, Biomarkers & Prevention

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok